Drug Patent Expirations for Apr 30, 2015

DrugPatentWatch provides competitive intelligence on small-molecule drugs and the 90,000 global patents covering them

Click the patents below for more details, or visit DrugPatentWatch.com for more options.

LAMISIL (terbinafine)
Novartis
Patent number: 5,681,849
Expiration Date: Apr 28, 2015


LAMISIL AT (terbinafine hydrochloride)
Novartis
Patent number: 5,681,849
Expiration Date: Apr 28, 2015


LAMISIL AT (terbinafine)
Novartis
Patent number: 5,681,849
Expiration Date: Apr 28, 2015


MAVIK (trandolapril)
Abbvie
Patent number: 5,744,496
Expiration Date: Apr 28, 2015


For more information try a free trial

Click here for reuse options!
Copyright 2015 Biotechblog

Leave a Reply

%d bloggers like this: